This MedLibrary.org supplementary page on Chiral resolution is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Chiral resolution in stereochemistry is a process for the separation of racemic compounds into their enantiomers.1 It is an important tool in the production of optically active drugs. Other terms with the same meaning are optical resolution and mechanical resolution.
One disadvantage of chiral resolution of racemates compared to direct asymmetric synthesis of one of the enantiomers is that only 50% of a desired enantiomer is obtained. Several methods exist.
Contents |
Resolution by crystallization
Typically 5-10% of all racemates are known to crystallize as mixtures of enantiopure crystals, so-called conglomerates 2. Louis Pasteur was the first to conduct chiral resolution when he discovered the concept of optical activity in the first place by the manual separation of left-handed and right-handed tartaric acid crystals in 1849. Later in 1882 he went on to demonstrate that by seeding a supersaturated solution of sodium ammonium tartrate with a d-crystal on one side of the reactor and a l-crystal on the opposite side that crystals of opposite handedness will form on the opposite side of the reactor.
This type of resolution called spontaneous resolution has also been demonstrated with racemic methadone.3 In a typical setup 50 grams dl-methadone is dissolved in petroleum ether and concentrated. Two millimeter-sized d- and l-crystals are added and after stirring for 125 hours at 40°C two large d- and l-crystals are recovered in 50% yield.
Another form of direct crystallization is preferential crystallization also called resolution by entrainment of one of the enantiomers. For example an added seed of (-)-hydrobenzoin to an ethanol solution of (±)-hydrobenzoin will have the (-)-enantiomer crystallizing out and after 15 cycles 97% optical purity can be obtained.
Chiral resolving agents
Derivatization of racemic compounds is possible with optically pure reagents forming pairs of diastereomers which can be separated by conventional techniques in physical chemistry. Derivatization is possible by salt formation between an amine and a carboxylic acid. Simple deprotonation affords the pure enantiomer. Examples of so-called chiral resolving agents are tartaric acid and brucine. The method was introduced (again) by Louis Pasteur in 1853 by resolving racemic tartaric acid with optically active (+)-cinchotoxine.
One modern-day method of chiral resolution is used in the organic synthesis of the drug Duloxetine:4
In one of its steps the racemic alcohol 1 is dissolved in a mixture of toluene and methanol to which solution is added optically active (S)-mandelic acid 3. The alcohol (S)-enantiomer forms an insoluble diastereomeric salt with the mandelic acid and can be filtered from the solution. Simple deprotonation with sodium hydroxide liberates free (S)-alcohol. In the meanwhile the (R)-alcohol remains in solution unaffected and is recycled back to the racemic mixture by epimerization with hydrochloric acid in toluene. This process is known as RRR synthesis in which the R's stand for Resolution-Racemization-Recycle.
Chiral column chromatography
- In chiral column chromatography the stationary phase is made chiral with similar resolving agents as described above.
External links
- Online course chirality Link
- List of chiral resolving agents at commercial supplier: Link
- Chiral resolution service: Link
References
- ^ William H. Porter (1991). "Resolution of chiral drugs". Pure Appl. Chem. 63 (8): 1119-1122, http://www.iupac.org/publications/pac/1991/pdf/6308x1119.pdf.
- ^ Enantiomers, racemates, and resolutions Jean Jacques, André Collet, Samuel H Wilen 1981 ISBN 0-471-08058-6
- ^ Harold E. Zaugg (1955). "A Mechanical Resolution of dl-Methadone Base". J. Am. Chem. Soc. 77 (10): 2910. doi:.
- ^ Yoshito Fujima, Masaya Ikunaka, Toru Inoue, and Jun Matsumoto (2006). "Synthesis of (S)-3-(N-Methylamino)-1-(2-thienyl)propan-1-ol: Revisiting Eli Lilly's Resolution-Racemization-Recycle Synthesis of Duloxetine for Its Robust Processes". Org. Process Res. Dev. 10 (5): 905-913. doi:.
|
||||||||||||||
Wikipedia content modification information:
- This page was last modified on 15 July 2008, at 11:03.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Chiral resolution".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.